GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » Debt-to-Equity

TMC Life Sciences Bhd (XKLS:0101) Debt-to-Equity : 0.24 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd Debt-to-Equity?

TMC Life Sciences Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was RM17.7 Mil. TMC Life Sciences Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was RM195.9 Mil. TMC Life Sciences Bhd's Total Stockholders Equity for the quarter that ended in Dec. 2023 was RM877.0 Mil. TMC Life Sciences Bhd's debt to equity for the quarter that ended in Dec. 2023 was 0.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for TMC Life Sciences Bhd's Debt-to-Equity or its related term are showing as below:

XKLS:0101' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.01   Max: 0.27
Current: 0.24

During the past 13 years, the highest Debt-to-Equity Ratio of TMC Life Sciences Bhd was 0.27. The lowest was 0.00. And the median was 0.01.

XKLS:0101's Debt-to-Equity is ranked better than
65.09% of 550 companies
in the Healthcare Providers & Services industry
Industry Median: 0.485 vs XKLS:0101: 0.24

TMC Life Sciences Bhd Debt-to-Equity Historical Data

The historical data trend for TMC Life Sciences Bhd's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd Debt-to-Equity Chart

TMC Life Sciences Bhd Annual Data
Trend May13 May14 May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.22 0.25 0.25

TMC Life Sciences Bhd Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.26 0.25 0.25 0.24

Competitive Comparison of TMC Life Sciences Bhd's Debt-to-Equity

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Debt-to-Equity falls into.



TMC Life Sciences Bhd Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

TMC Life Sciences Bhd's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

TMC Life Sciences Bhd's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TMC Life Sciences Bhd  (XKLS:0101) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


TMC Life Sciences Bhd Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


TMC Life Sciences Bhd (XKLS:0101) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd (XKLS:0101) Headlines

No Headlines